Rxo, Inc.
RXO
Revenue
930.00M
▲17.00M▲1.86%
3 Months ChangeAssets
1.81B
▲14.00M▲0.7782%
3 Months ChangeLiabilities
1.23B
▲17.00M▲1.40%
3 Months ChangeFree Cash Flow
-4.00M
▼-34.00M▼-113.33%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001140361-24-043904
2024-09-25
Form 8-K
ID: 0000950142-24-002444
2024-09-16
Form 8-K
ID: 0000950142-24-002381
2024-09-11
Form 8-K
ID: 0001104659-24-098769
2024-09-09
Form 8-K
ID: 0001104659-24-097983
2024-09-09
Form 8-K
ID: 0001104659-24-097965
2024-08-12
Form 8-K
ID: 0001104659-24-088393
2024-08-09
Form 8-K
ID: 0001104659-24-087525
2024-08-07
Form 10-Q
ID: 0001929561-24-000102
2024-08-07
Form 8-K
ID: 0001929561-24-000098